To further confirm that B-1 lymphocytes are responsible for the aggressiveness of the tumor, B16F10 melanoma cells were co-cultivated with purified peritoneal B-1 lymphocytes (CD19+CD23-; S1 Fig) or the non-B-1 peritoneal cells. The gene discussed is CD19; the disease is melanoma.